Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Diverio

Showing results (41-50 of 66) with videos related to

Pageof 7
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 13, 1998
The role of all-trans-retinoic acid (ATRA) treatment in newly-diagnosed acute promyelocytic leukemia patients aged > 60 yearsR Latagliata, G Avvisati, F Lo Coco, et al.
Blood|April 15, 1991
Molecular evaluation of response to all-trans-retinoic acid therapy in patients with acute promyelocytic leukemiaF Lo Coco, G Avvisati, D Diverio, et al.
Leukemia|September 27, 2003
Allogeneic stem cell transplantation for advanced acute promyelocytic leukemia: results in patients treated in second molecular remission or with molecularly persistent diseaseF Lo-Coco, A Romano, A Mengarelli, et al.
Leukemia|January 17, 2003
C-fms expression correlates with monocytic differentiation in PML-RAR alpha+ acute promyelocytic leukemiaR Riccioni, E Saulle, S Militi, et al.
Oncogene|May 8, 2009
PLZF-mediated control on c-kit expression in CD34(+) cells and early erythropoiesisI Spinello, M T Quaranta, L Pasquini, et al.
British Journal of Haematology|November 28, 2001
Prolonged molecular remission in advanced acute promyelocytic leukaemia after treatment with gemtuzumab ozogamicin (Mylotarg CMA-676)M C Petti, M B Pinazzi, D Diverio, et al.
British Journal of Haematology|August 1, 1991
Rearrangements of the RAR-alpha gene in acute promyelocytic leukaemia: correlations with morphology and immunophenotypeF Lo Coco, G Avvisati, D Diverio, et al.
Leukemia|June 1, 2002
Assessment of minimal residual disease (MRD) in CBFbeta/MYH11-positive acute myeloid leukemias by qualitative and quantitative RT-PCR amplification of fusion transcriptsA Guerrasio, C Pilatrino, D De Micheli, et al.
The Journal of Clinical Investigation|May 29, 1998
The PML/RARalpha fusion protein inhibits tumor necrosis factor-alpha-induced apoptosis in U937 cells and acute promyelocytic leukemia blastsU Testa, F Grignani, P Samoggia, et al.
Leukemia|October 26, 2002
Alterations of the FLT3 gene in acute promyelocytic leukemia: association with diagnostic characteristics and analysis of clinical outcome in patients treated with the Italian AIDA protocolN I Noguera, M Breccia, M Divona, et al.
Pageof 7

Showing results (41-50 of 66) with videos related to

Sort By:
Pageof 7
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 13, 1998
The role of all-trans-retinoic acid (ATRA) treatment in newly-diagnosed acute promyelocytic leukemia patients aged > 60 yearsR Latagliata, G Avvisati, F Lo Coco, et al.
Blood|April 15, 1991
Molecular evaluation of response to all-trans-retinoic acid therapy in patients with acute promyelocytic leukemiaF Lo Coco, G Avvisati, D Diverio, et al.
Leukemia|September 27, 2003
Allogeneic stem cell transplantation for advanced acute promyelocytic leukemia: results in patients treated in second molecular remission or with molecularly persistent diseaseF Lo-Coco, A Romano, A Mengarelli, et al.
Leukemia|January 17, 2003
C-fms expression correlates with monocytic differentiation in PML-RAR alpha+ acute promyelocytic leukemiaR Riccioni, E Saulle, S Militi, et al.
Oncogene|May 8, 2009
PLZF-mediated control on c-kit expression in CD34(+) cells and early erythropoiesisI Spinello, M T Quaranta, L Pasquini, et al.
British Journal of Haematology|November 28, 2001
Prolonged molecular remission in advanced acute promyelocytic leukaemia after treatment with gemtuzumab ozogamicin (Mylotarg CMA-676)M C Petti, M B Pinazzi, D Diverio, et al.
British Journal of Haematology|August 1, 1991
Rearrangements of the RAR-alpha gene in acute promyelocytic leukaemia: correlations with morphology and immunophenotypeF Lo Coco, G Avvisati, D Diverio, et al.
Leukemia|June 1, 2002
Assessment of minimal residual disease (MRD) in CBFbeta/MYH11-positive acute myeloid leukemias by qualitative and quantitative RT-PCR amplification of fusion transcriptsA Guerrasio, C Pilatrino, D De Micheli, et al.
The Journal of Clinical Investigation|May 29, 1998
The PML/RARalpha fusion protein inhibits tumor necrosis factor-alpha-induced apoptosis in U937 cells and acute promyelocytic leukemia blastsU Testa, F Grignani, P Samoggia, et al.
Leukemia|October 26, 2002
Alterations of the FLT3 gene in acute promyelocytic leukemia: association with diagnostic characteristics and analysis of clinical outcome in patients treated with the Italian AIDA protocolN I Noguera, M Breccia, M Divona, et al.
Pageof 7